PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24468070-1	2014	BACKGROUND: The aim of this study is to investigate the outcomes of magnetic resonance imaging (MRI)-based individual thrombolysis therapy using recombinant tissue plasminogen activator (rt-PA) in patients with superacute infarction, comparing the outcome in 1 group of patients treated within 4.5 hours compared with 4.5- to 12-hour window treatment group.	Hydrocortisone	187-189	chromosome 20 open reading frame 181	Homo sapiens	157-185	
23008384-2	2012	Intravenous recombinant tissue plasminogen activator (rt-PA), the only established revascularization therapy approved by the US Food & Drug Administration for AIS, may be less effective for large artery occlusion.	Hydrocortisone	54-56	chromosome 20 open reading frame 181	Homo sapiens	24-52	
25390842-1	2009	PURPOSE: The authors report a case of retinal pigment epithelial (RPE) tear following pars plana vitrectomy (PPV), subretinal recombinant tissue plasminogen activator (rt-PA), and intravitreal gas administration for the displacement of large submacular hemorrhage.	Hydrocortisone	25-27	chromosome 20 open reading frame 181	Homo sapiens	138-166	
22311232-1	2012	BACKGROUND: Angioedema is an underappreciated and potentially life-threatening complication of intravenous (IV) recombinant tissue plasminogen activator (rt-PA).	Hydrocortisone	154-156	chromosome 20 open reading frame 181	Homo sapiens	124-152	
11767946-0	2001	Elimination of hydrocortisone from the medium enables tissue plasminogen activator gene expression by normal and immortalized nonmalignant human epithelial cells.	Hydrocortisone	15-29	chromosome 20 open reading frame 181	Homo sapiens	54-82	
11767946-2	2001	We found that hydrocortisone diminished tissue plasminogen activator (tPA) production to an undetectable level.	Hydrocortisone	14-28	chromosome 20 open reading frame 181	Homo sapiens	40-68	
11767946-2	2001	We found that hydrocortisone diminished tissue plasminogen activator (tPA) production to an undetectable level.	Hydrocortisone	14-28	chromosome 20 open reading frame 181	Homo sapiens	70-73	
11767946-3	2001	The removal of hydrocortisone increased urokinase plasminogen activator (uPA) activity within 24-48 h and tPA activity within 48-72 h, and converted the cells to a more elongated and fibroblastic phenotype.	Hydrocortisone	15-29	chromosome 20 open reading frame 181	Homo sapiens	106-109	
11767946-8	2001	The omission of hydrocortisone increased tPA levels significantly in BEAS-2B cell cultures, and in NHBE cell cultures tPA became detectable at 72 h. No PA complexes were seen in these two cell types.	Hydrocortisone	16-30	chromosome 20 open reading frame 181	Homo sapiens	41-44	
11470706-1	2001	OBJECTIVE: To investigate the efficacy and safety of treating submacular hemorrhages secondary to age-related macular degeneration (ARMD) with intravitreous recombinant tissue plasminogen activator (rt-PA) and gas under various conditions.	Hydrocortisone	199-201	chromosome 20 open reading frame 181	Homo sapiens	169-197	
24981554-3	2015	METHODS: We conducted a systematic review of studies that used IV recombinant tissue plasminogen activator (rt-PA) therapy in China and the USA published between January 1950 and April 2012.	Hydrocortisone	108-110	chromosome 20 open reading frame 181	Homo sapiens	78-106	
11296577-1	2001	OBJECTIVE: Intravenous recombinant tissue plasminogen activator (rt-PA) is the only therapy of proven value for patients with acute ischemic stroke (AIS).	Hydrocortisone	65-67	chromosome 20 open reading frame 181	Homo sapiens	35-63	
8111066-1	1994	A well-characterized in vitro model system composed of thrombin-stimulated gel-filtered human platelets, fibrin-(ogen), plasminogen, and recombinant tissue plasminogen activator (rt-PA) was used to examine the relationship between platelet-fibrin adhesive interactions and the lytic resistance of a platelet-rich thrombus.	Hydrocortisone	179-181	chromosome 20 open reading frame 181	Homo sapiens	149-177	
2105879-2	1990	She was given 70 mg recombinant tissue plasminogen activator (rt-PA) by continuous intravenous drip over two hours.	Hydrocortisone	62-64	chromosome 20 open reading frame 181	Homo sapiens	32-60	
3102144-1	1987	A mathematic model of the systemic fibrinogenolysis that accompanies coronary thrombolysis with recombinant tissue plasminogen activator (rt-PA) has been devised.	Hydrocortisone	138-140	chromosome 20 open reading frame 181	Homo sapiens	108-136	
24959070-9	2014	Alteplase (recombinant tissue plasminogen activator [rt-PA]) was administered during cardiopulmonary resuscitation (CPR) and four (36.3%) patients responded and survived without sequelae.	Hydrocortisone	53-55	chromosome 20 open reading frame 181	Homo sapiens	23-51	
24926305-2	2014	Recent findings suggest that current smokers may present higher recanalization rates after intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (rt-PA).	Hydrocortisone	168-170	chromosome 20 open reading frame 181	Homo sapiens	138-166